Bartomeu Massutí
0000-0002-7608-3952
3 papers found
Refreshing results…
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
Phase II Clinical Trial with Metronomic Oral Vinorelbine and Tri-weekly Cisplatin as Induction Therapy, Subsequently Concomitant with Radiotherapy (RT) in Patients with Locally Advanced, Unresectable, Non-Small Cell Lung Cancer (NSCLC). Analysis of Survival and Value of ctDNA for Patient Selection
Missing publications? Search for publications with a matching author name.